ocr: Figure 2: Estimated Probability of Patients Taking a Second Dose of MAXALT Tablets or Other Medication for Migraines Over the 24 Hours Following the Initial Dose - - of Study TreatmenttTT 100% 100% 90% Placebo 90% **** MAXALT5mg 80% - - : - MAXALT1 10mg 80% a a 70% 70% - 60% 60% - 50% 50% 40% 40% L 2 30% 30% 20% 20% 10% 10% 0% 0% 2 6 8 10 12 14 16 18 20 22 24 Hours Post-Dose tttThis Kaplan-Meier plot is based on data obtained in 4 placebo-controlled outpatient clinical trials (Studies 1,2,3, and 4). Patients not using additional treatments were censored at 24 hours. The plot includes both pati ...
